Skip to main content
Log in

Hyperserotonemia in Adults with Autistic Disorder

  • Original Paper
  • Published:
Journal of Autism and Developmental Disorders Aims and scope Submit manuscript

Abstract

Hyperserotonemia is the most consistent serotonin-related finding in autism. The basis of this phenomenon, and its relationship to the central serotonergic dysfunction remains unclear. Platelet serotonin level (PSL) in 53 autistic adults and 45 healthy controls was measured. Mean PSL in autistic group (75.7 ± 37.4 ng/μL) was significantly higher than the control sample (59.2 ± 16.2 ng/μL) due to a presence of hyperserotonemic subjects which comprised 32% of the patients. PSL of autistic subjects did not correlate with the severity of symptoms, as measured by total CARS score, or the degree of mental retardation. However, significant negative relationship was observed between PSL and speech development, indicating the relationship between the peripheral 5HT concentrations and verbal abilities in autistic subjects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Anderson, G. M. (1987). Monoamines in autism: An update of neurochemical research on a pervasive developmental disorder. Medical Biology, 65, 67–74.

    PubMed  CAS  Google Scholar 

  • Campbell, M., Friedman, E., DeVito, E., Greenspan, L., & Collins, P. J. (1974). Blood serotonin in psychotic and brain damaged children. Journal of Autism and Childhood Schizophrenia, 4, 33–41.

    Article  PubMed  CAS  Google Scholar 

  • Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., & Chugani, H. T. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287–295.

    Article  PubMed  CAS  Google Scholar 

  • Chugani, D. C., Muzik, O., Rothermel, R., Behen, M., Chakraborty, P., Mangner, T., et al. (1997). Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Annals of Neurology, 42, 666–669.

    Article  PubMed  CAS  Google Scholar 

  • Cook, E. H. Jr., Arora, R. C., Anderson, G. M., Berry-Kravis, E. M., Yan, S. Y., Yeoh, H. C., et al. (1993). Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sciences, 52, 2005–2015.

    Article  PubMed  Google Scholar 

  • Cook, E. H. Jr., & Leventhal, B. L. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8, 348–354.

    Article  PubMed  CAS  Google Scholar 

  • Cook, E. H. Jr., Leventhal, B. L., Heller, W., Metz, J., Wainwright, M., & Freedman, D. X. (1990). Autistic children and their first-degree relatives: Relationships between serotonin and norepinephrine levels and intelligence. Journal of Neuropsychiatry and Clinical Neurosciences, 2, 268–274.

    PubMed  Google Scholar 

  • Coutinho, A. M., Oliveira, G., Morgadinho, T., Fesel, C., Macedo, T. R., Bento, C., et al. (2004). Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Molecular Psychiatry, 9, 264–271.

    Article  PubMed  CAS  Google Scholar 

  • Croonenberghs, J., Delmeire, L., Verkerk, R., Lin, A. H., Meskal, A., Neels, H., et al. (2000). Peripheral markers of serotonergic and noradrenergic function in post-pubertal, caucasian males with autistic disorder. Neuropsychopharmacology, 22, 275–283.

    Article  PubMed  CAS  Google Scholar 

  • Croonenberghs, J., Verkerk, R., Scharpe, S., Deboutte, D., & Maes, M. (2005). Serotonergic disturbances in autistic disorder: L-5-hydroxytryptophan administration to autistic youngsters increases the blood concentrations of serotonin in patients but not in controls. Life Sciences, 76, 2171–2183.

    Article  PubMed  CAS  Google Scholar 

  • Cuccaro, M. L., Wright, H. H., Abramson, R. K., Marsteller, F. A., & Valentine, J. (1993). Whole-blood serotonin and cognitive functioning in autistic individuals and their first-degree relatives. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 94–101.

    PubMed  CAS  Google Scholar 

  • Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman S., & Iyengar, R. (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30, 582–589.

    Article  PubMed  CAS  Google Scholar 

  • Janusonis, S. (2005). Serotonergic paradoxes of autism replicated in a simple mathematical model. Medical Hypotheses, 64, 742–750.

    Article  PubMed  CAS  Google Scholar 

  • Jernej, B., Banovic, M., Cicin-Sain, L., Hranilovic, D., Balija, M., Oreskovic, D., & Folnegovic-Smalc, V. (2000). Physiological characteristics of platelet/circulatory serotonin: Study on a large human population. Psychiatry Research, 94, 153–162.

    Article  PubMed  CAS  Google Scholar 

  • Jernej, B., Cicin-Sain, L., & Iskric, S. (1988). A simple and reliable method for monitoring platelet serotonin levels in rats. Life Sciences, 43, 1663–1670.

    Article  PubMed  CAS  Google Scholar 

  • Jones, M. B., & Szatmari, P. (2002). A risk-factor model of epistatic interaction, focusing on autism. American Journal of Medical Genetics, 114, 558–565.

    Article  PubMed  Google Scholar 

  • Kuperman, S., Beeghly, J., Burns, T., & Tsai, L. (1987). Association of serotonin concentration to behavior and IQ in autistic children. Journal of Autism and Developmental Disorders, 17, 133–140.

    Article  PubMed  CAS  Google Scholar 

  • Limpert, E., Stahel, W. A., & Abbt, M. (2001). Log-normal ndistributions across the sciences: Keyes and clues. BioScience, 51, 341–352.

    Article  Google Scholar 

  • Marazziti, D., Muratori, F., Cesari, A., Masala, I., Baroni, S., Giannaccini, G., et al. (2000). Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry, 33, 165–168.

    Article  PubMed  CAS  Google Scholar 

  • McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., et al. (1998). Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767–776.

    Article  PubMed  CAS  Google Scholar 

  • McDougle, C. J., Naylor, S. T., Cohen D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996a). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.

    CAS  Google Scholar 

  • McDougle, C .J., Naylor, S. T., Cohen, D. J., Aghajanian, G. K., Heninger, G. R., & Price, L. H. (1996b). Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry, 53, 993–1000.

    CAS  Google Scholar 

  • Muhle, R., Trentacoste, S. V., & Rapin, I. (2004). The genetics of autism. Pediatrics, 13, 472–486.

    Article  Google Scholar 

  • Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., & Minderaa, R. B. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry 43, 491–499.

    Article  PubMed  Google Scholar 

  • Owley, T., Leventhal, B. L., & Cook, E. H. (2003). Childhood Disorders: The autism spectrum disorders. In A. Tasman, J. Kay, & J. A. Lieberman (Eds.), Psychiatry. 2nd ed., (pp. 757–770). Chichester: Wiley.

    Google Scholar 

  • Ritvo, E., Yuwiler, A., Geller, E., Plotkin, S., Mason, A., & Saeger, K. (1971). Maturational changes in blood serotonin levels and platelet counts. Biochemical Medicine 5, 90–96.

    Article  PubMed  CAS  Google Scholar 

  • Schopler, E., Reichler, R. J., DeVellis, R. F., & Daly, K. (1980). Toward objective classification of childhood autism: Childhood autism rating scale (CARS). Journal of Autism and Developmental Disorders 10, 91–103.

    Article  PubMed  CAS  Google Scholar 

  • Spivak, B., Golubchik, P., Mozes, T., Vered, Y., Nechmad, A., Weizman, A., & Strous, R. D. (2004). Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology, 50, 157–160.

    Article  PubMed  CAS  Google Scholar 

  • Whitaker-Azmitia, P. M. (2001). Serotonin and brain development: Role in human developmental diseases. Brain Research Bulletin, 56, 479–485.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the Ministry of Science Education and Sports of the Republic of Croatia. The authors wish to thank Mrs. Drina Bagaric, a medical laboratory engineer, for her skillful, kind, and gentle approach to the patients during blood sampling, and to Mrs. Katarina Karlo, a senior technician, for her assistance in PSL measurements.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dubravka Hranilovic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hranilovic, D., Bujas-Petkovic, Z., Vragovic, R. et al. Hyperserotonemia in Adults with Autistic Disorder. J Autism Dev Disord 37, 1934–1940 (2007). https://doi.org/10.1007/s10803-006-0324-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10803-006-0324-6

Keywords

Navigation